FDA Approves Johnson & Johnson’s Ottava Surgical Robot

Four robotic arms embedded directly into a standard surgical table have cleared federal regulators for use in the operating room. Johnson & Johnson secured FDA marketing authorization this Wednesday for its Ottava system, a move that signals a major shift in how the company approaches soft-tissue surgery.

Today, 15:15· Money Talk· 786 reads

FDA Approves Johnson & Johnson’s Ottava Surgical Robot

The system is designed for a broad range of general procedures, specifically gastric bypass, gastric sleeve, small-bowel resection, appendectomy, and hiatal-hernia repair. By integrating the robotics into the table itself, the New Brunswick-based firm aims to streamline the surgical environment.

Commercial rollout begins immediately with select U.S. customers. The company intends to prioritize early success in these initial clinical settings before expanding the system’s use to additional medical indications and seeking entry into further regulatory jurisdictions.

FDA Approves Johnson & Johnson’s Ottava Surgical Robot

Comments (0)